Skip to main content

Michael Carrel

Equibles does not estimate personal net worth.

Get an email with a short summary when AtriCure, Inc. publishes a filing, an earnings call transcript or a press release.

Get ATRC alerts

About Michael Carrel

Michael Carrel is recorded as CEO and Board Member at AtriCure, Inc. (ATRC). Michael Carrel has spoken on 16 earnings calls and 1 other investor event across 1 company, most recently for AtriCure, Inc. on August 11, 2026. AtriCure, Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at AtriCure, Inc. includes Michael H. Carrel (CEO and Board Member), Robert S. White (Chairman), Angela L. Wirick (CFO) and 7 others.

Michael Carrel on recent calls

“Well, thank you for having us here, Bill and Canaccord today. We'll kind of do a couple of quick overview slides. I think the number one thing to really understand and know about us is that we are focused on helping patients with complex AFib and pain after surgery.”
CEO, Canaccord Genuity 46th Annual Growth Conference ·
“Asecure delivered solid second quarter results with worldwide revenue of $154 million and growth of 13%.”
CEO, Q2 2026 AtriCure, Inc. Earnings Conference Call ·
“AtriCure is off to a strong start in 2026 with worldwide revenue of $140 million in the first quarter, reflecting 14% growth year-over-year.”
CEO, AtriCure, Inc. Q1 FY2026 Earnings Call ·
“2025 was an exceptional year at AtriCure with achievements across our business.”
CEO, AtriCure, Inc. Q4 FY2025 Earnings Call ·
“We had a very strong third quarter with total revenue of $134 million, reflecting a 16% increase year-over-year. Our growth was driven across key franchises globally, demonstrating the expanding adoption of our therapies and breadth of market opportunities.”
CEO, AtriCure, Inc. Q3 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at AtriCure, Inc.

Recent activity

Show 5 earlier activities